HeFH Base Editor Shows Promise in Chinese Clinical Trial - Inside Precision Medicine

HeFH Base Editor Shows Promise in Chinese Clinical Trial  Inside Precision MedicineCRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia  NatureBase editing milestone for familial hypercholesterolemia  NatureIn vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial  Nature